Drug Profile
Tenofovir disoproxil orotate - Dong-A ST
Alternative Names: DA 2802Latest Information Update: 21 Apr 2021
Price :
$50
*
At a glance
- Originator Dong-A ST
- Class Amines; Antiretrovirals; Antivirals; Esters; Phosphonic acids; Purines; Pyrimidines; Small molecules
- Mechanism of Action Nucleotide reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Hepatitis B
Most Recent Events
- 21 Apr 2021 Phase-III development is ongoing for Hepatitis B in South Korea (PO) (NCT02967939)
- 05 Oct 2020 No development reported - Phase-III for Hepatitis B in South Korea (PO) (Dong-A ST website, October 2020)
- 15 Jul 2019 Dong-A ST completes a phase-III clinical trials in Hepatitis B in South Korea (PO) (NCT02967939)